Compare McKesson Corporation (MCK) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Medpace Holdings Inc — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: McKesson Corporation is far larger — about 6.5× Medpace Holdings Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MCK | MEDP | |
|---|---|---|
Market Cap | $97.35B | $15.08B |
Sector | Health | Technology |
52-Week High | $995.69 | $620.59 |
52-Week Low | $659.01 | $308.88 |
Enterprise Value | $101.98B | $14.55B |
Dividend Yield | 0.39% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
